Home > Financial Ratios > STRIDES PHARMA SCIENCE

STRIDES PHARMA SCIENCE
Core EBITDA Margin

    Back to All Ratios
STRIDES PHARMA SCIENCE is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for STRIDES PHARMA SCIENCE
Please provide your vote to see the results

STRIDES PHARMA SCIENCE Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Margin(%) 11.736.17-0.4011.4510.95

What is the latest Core EBITDA Margin ratio of STRIDES PHARMA SCIENCE ?

The latest Core EBITDA Margin ratio of STRIDES PHARMA SCIENCE is 11.73 based on Mar2024 Consolidated results.
Year Core EBITDA Margin
Mar202411.73
Mar20236.17
Mar2022-0.40
Mar202111.45
Mar202010.95

How is Core EBITDA Margin of STRIDES PHARMA SCIENCE Trending?

Years Core EBITDA Margin % Change
Mar2024 11.73
90.11
Mar2023 6.17
Positive
Mar2022 -0.4
Negative
Mar2021 11.45
4.57
Mar2020 10.95 -

Other Financial Ratios of STRIDES PHARMA SCIENCE


Compare Core EBITDA Margin ratio of peers of STRIDES PHARMA SCIENCE

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
STRIDES PHARMA SCIENCE ₹6,364.6 Cr -6.4% -51.2% 22.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹429,361.0 Cr -1.4% 1.2% 46.9% Stock Analytics
DIVIS LABORATORIES ₹155,274.0 Cr -1.4% 1.8% 60% Stock Analytics
CIPLA ₹117,144.0 Cr -0.3% -3.3% 19.1% Stock Analytics
DR REDDYS LABORATORIES ₹104,134.0 Cr 0.8% 1.8% 13.5% Stock Analytics
ZYDUS LIFESCIENCES ₹97,554.4 Cr -1.7% 1.2% 53.9% Stock Analytics


STRIDES PHARMA SCIENCE Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
STRIDES PHARMA SCIENCE

-6.4%

-51.2%

22.7%

SENSEX

-1%

3.9%

16%


You may also like the below Video Courses